Palisade Capital Management’s AdaptHealth AHCO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$25.7M	Sell	2,162,681 -129,166	-6%	-$1.32M	0.86%	36
2025 Q4	$22.8M	Sell	2,291,847 -310,645	-12%	-$2.97M	0.68%	55
2025 Q3	$23.3M	Sell	2,602,492 -30,233	-1%	-$280K	0.63%	57
2025 Q2	$24.8M	Sell	2,632,725 -78,417	-3%	-$692K	0.7%	49
2025 Q1	$29.4M	Buy	2,711,142 +297,268	+12%	+$2.99M	0.84%	36
2024 Q4	$23M	Buy	2,413,874 +374,919	+18%	+$3.79M	0.61%	63
2024 Q3	$22.9M	Sell	2,038,955 -128,043	-6%	-$1.36M	0.61%	62
2024 Q2	$21.7M	Buy	2,166,998 +629,297	+41%	+$6.39M	0.59%	64
2024 Q1	$17.7M	Buy	1,537,701 +50,138	+3%	+$426K	0.47%	80
2023 Q4	$10.8M	Sell	1,487,563 -185,477	-11%	-$1.46M	0.29%	109
2023 Q3	$15.2M	Buy	1,673,040 +26,650	+2%	+$319K	0.43%	85
2023 Q2	$20M	Buy	1,646,390 +268,425	+19%	+$2.99M	0.53%	66
2023 Q1	$17.1M	Buy	1,377,965 +172,934	+14%	+$3.18M	0.46%	77
2022 Q4	$23.2M	Sell	1,205,031 -27,968	-2%	-$591K	0.62%	54
2022 Q3	$23.2M	Buy	1,232,999 +101,571	+9%	+$2.09M	0.66%	50
2022 Q2	$20.4M	Buy	1,131,428 +16,248	+1%	+$264K	0.55%	62
2022 Q1	$17.9M	Buy	1,115,180 +257,908	+30%	+$4.64M	0.41%	85
2021 Q4	$21M	Buy	857,272 +127,493	+17%	+$2.99M	0.42%	79
2021 Q3	$17M	Buy	729,779 +271,525	+59%	+$6.57M	0.37%	96
2021 Q2	$12.6M	Sell	458,254 -185,988	-29%	-$5.3M	0.28%	114
2021 Q1	$23.7M	Buy	+644,242	New	+$22.8M	0.56%	58

Other funds holding AHCO